Neurophysiological consequences of synapse loss in progressive supranuclear palsy
View ORCID ProfileNatalie E. Adams, View ORCID ProfileAmirhossein Jafarian, View ORCID ProfileAlistair Perry, View ORCID ProfileMatthew A. Rouse, View ORCID ProfileAlexander D. Shaw, View ORCID ProfileAlexander G. Murley, View ORCID ProfileThomas E. Cope, W. Richard Bevan-Jones, View ORCID ProfileLuca Passamonti, View ORCID ProfileDuncan Street, View ORCID ProfileNegin Holland, David Nesbitt, View ORCID ProfileLaura E. Hughes, View ORCID ProfileKarl J Friston, View ORCID ProfileJames B. Rowe
doi: https://doi.org/10.1101/2022.06.22.22276697
Natalie E. Adams
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
Amirhossein Jafarian
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
Alistair Perry
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
Matthew A. Rouse
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
Alexander D. Shaw
3Washington Singer Laboratories, University of Exeter, Exeter, EX4 4QG, UK
Alexander G. Murley
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
Thomas E. Cope
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
W. Richard Bevan-Jones
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
Luca Passamonti
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
Duncan Street
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
Negin Holland
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
David Nesbitt
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
Laura E. Hughes
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
Karl J Friston
4Wellcome Centre for Human Neuroimaging, University College London, WC1N 3AR, UK
James B. Rowe
1Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, United Kingdom
2MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The DCM used in this study was adapted from https://gitlab.com/tallie/edcm, as described in Adams et al.30 with prior model parameters altered according to Supplementary Table 2.
Posted June 23, 2022.
Neurophysiological consequences of synapse loss in progressive supranuclear palsy
Natalie E. Adams, Amirhossein Jafarian, Alistair Perry, Matthew A. Rouse, Alexander D. Shaw, Alexander G. Murley, Thomas E. Cope, W. Richard Bevan-Jones, Luca Passamonti, Duncan Street, Negin Holland, David Nesbitt, Laura E. Hughes, Karl J Friston, James B. Rowe
medRxiv 2022.06.22.22276697; doi: https://doi.org/10.1101/2022.06.22.22276697
Neurophysiological consequences of synapse loss in progressive supranuclear palsy
Natalie E. Adams, Amirhossein Jafarian, Alistair Perry, Matthew A. Rouse, Alexander D. Shaw, Alexander G. Murley, Thomas E. Cope, W. Richard Bevan-Jones, Luca Passamonti, Duncan Street, Negin Holland, David Nesbitt, Laura E. Hughes, Karl J Friston, James B. Rowe
medRxiv 2022.06.22.22276697; doi: https://doi.org/10.1101/2022.06.22.22276697
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2986)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12845)
- Forensic Medicine (12)
- Gastroenterology (838)
- Genetic and Genomic Medicine (4650)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2959)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (937)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4439)
- Nursing (239)
- Nutrition (653)
- Oncology (2310)
- Ophthalmology (655)
- Orthopedics (260)
- Otolaryngology (328)
- Pain Medicine (285)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1205)
- Primary Care Research (506)
- Public and Global Health (7036)
- Radiology and Imaging (1557)
- Respiratory Medicine (926)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (494)
- Toxicology (60)
- Transplantation (213)
- Urology (186)